8th Asian College of Neuropsychopharmacology Annual Meeting (AsCNP 2023) Conjoined with the 11th China Schizophrenia Forum and Shaanxi Provincial Medical Association Annual Meeting in Psychiatry – Second Announcement

Dear Colleagues,

Hello everyone!

Neuropsychiatric disorders have become a leading cause of disability worldwide, imposing a substantial disease burden in the Asian region. With advancements in diagnostic and therapeutic technologies, new pharmacological treatments and management strategies have been introduced and continuously refined, benefiting an increasing number of patients with mental disorders. To promote academic integration, the 8th Annual Meeting of the Asian College of Neuropsychopharmacology, the 11th China Schizophrenia Forum, and the Academic Annual Conference on Psychiatry of the Shaanxi Medical Association will be held atSeptember 21–24, 2023, held at the Qujiang International Conference Center in Xi'an, China.

This conference is themed"Tracing Origins · Integration · Innovation"Centered on this theme and grounded in psychopharmacology and innovative diagnostic and therapeutic technologies, while integrating numerous cutting-edge scientific disciplines, this initiative aims to foster academic research and technical exchange in the field of psychiatry across the Asia-Pacific region, enhance the standards of diagnosis and treatment for mental disorders, promote the flourishing development of psychiatry in Asia, and improve prognoses for psychiatric patients in the region. Your participation is cordially invited!

President of the Asian College of Neuropsychopharmacology

July 03, 2023

Conference Name:The 8th Annual Meeting of the Asian College of Neuropsychopharmacology, the 11th China Schizophrenia Forum, and the Academic Annual Meeting of Psychiatry of the Shaanxi Medical Association

Meeting Time:September 21–24, 2023

Venue:China · Xi'an Qujiang International Conference Center

Conference Website:https://ascnp2023.ccmtv.cn

Organization

Guiding Organizations:

Chinese Society of Psychiatry, Chinese Medical Association

Schizophrenia Collaborative Group, Chinese Society of Psychiatry, Chinese Medical Association

Biological Psychiatry Group, Branch of Psychiatry, Chinese Medical Association

Schizophrenia Working Committee, Psychiatric Physicians Branch, Chinese Medical Doctor Association

Schizophrenia Clinical Research Alliance of the Branch on Foundations and Clinical Practice of Psychiatry, Chinese Society for Neuroscience

Organizer:

Chinese Medical Education Association

Asian College of Neuropsychopharmacology (AsCNP)

CCMTV Psychiatry Channel

Beijing Medical and Health Public Welfare Foundation

Co-organizers:

Beijing Society of Integrative Medicine

Beijing Zhongwei Medical and Health Science & Technology Development Center

Peking University Sixth Hospital

The First Affiliated Hospital of Xi'an Jiaotong University

Organizer: 

Shanghai Yiling Medical Information Technology Co., Ltd.

This conference focuses on disease areas including psychopharmacology, schizophrenia, mood disorders, substance abuse, and sleep disorders, exploring new concepts, research, medications, technologies, and trends across the entire continuum of care—from diagnosis and treatment to optimization and recovery outcomes. The latest conference schedule is as follows:

● Target Audience for Submissions:

Physicians, technical personnel, and enrolled students in psychiatry and related fields from China and abroad

● Scope of Call for Papers:

1. Research Topics: Addictive Disorders, Antidepressants, Antipsychotics, Anxiety Disorders, Anxiolytics, Attention Deficit Disorder, Autism, Bipolar Disorder, Neuromodulation and Related Technologies, Neuroinflammatory Mechanisms in Mental Disorders, Gut-Brain-Microbiome Axis and Mental Health, Child and Adolescent Psychiatric Disorders, COVID-19 and Mental Health, Dementia, Depression, Digital Therapeutics in Psychiatry, Eating Disorders, Epilepsy, Mood Stabilizers, Obsessive-Compulsive Disorder, Pain, Pain Disorders, Personality Disorders, Pharmacoeconomics, Psychotherapy, Post-Traumatic Stress Disorder, Premenstrual Syndrome, Schizophrenia, Sexual Dysfunction, Sleep Disorders, Suicide, etc.

2. Research Types: Clinical, Basic, and Translational Research, etc.

3. Research Methods: Animal models and related techniques, biochemistry, biostatistics and computational methods, epidemiology, various omics and big data, genetic and molecular methods, immunology, in vivo neuroimaging, neurophysiology and electrophysiology, neuropsychology, pharmacology, autopsy and pathology, systems biology, cell culture and live-cell imaging, etc.

● Submission Guidelines:

1. Submissions should be academic papers or previous conference abstracts that have not been formally published in domestic or international journals. Please note that preliminary research outputs, including manuscripts deposited on preprint servers, are eligible for abstract submission.

2. Submission Format and Word Count Requirements: Submit in the form of a paper abstract,3,200 characterswithin (excluding spaces; images, charts, or tables are not accepted)

3. Abstract structure: It should include background, methods, results, and discussion. The abstract must be inEnglish Writing, with strong scientific rigor, clear emphasis, reliable data, appropriate conclusions, and smooth, concise language

4. If the oral presentation is not accepted, submitters will have the option during the submission process to choose whether their abstract should be considered for poster presentation.

● Call for Papers Submission:Click to view submission guidelines

● Submission Deadline:July 31, 2023

1. Credit Awarding

Successful registration for the conference will award National Class I Continuing Medical Education (CME) credits (6 credits) [Project No.: 2023-12-07-234 (National)]. Please accurately provide your personal information; CME credits will not be granted to individuals who fail to register via the conference website.

2. Registration Method

1) Online Registration: Log in to the conference website, click “Register Now,” fill in your personal information online, and pay the registration fee to complete the registration. Registration URL: https://ascnp2023.ccmtv.cn//admin.php/meeting/home/Index/index/582/27

2) On-site Registration: Fill in the registration information as required during check-in. Payment can be made by swiping a bank card or paying in cash to complete the registration.

3) Team Registration: Limited to Xi’an local teams. For team registration inquiries, please contact Chen Min (Contact: 13701842000).

3. Registration Fee

4. Registration Instructions

Accommodation and transportation expenses are to be covered by the individual.

Conference Chair:Prof. Si Tianmei

● Email: si.tian-mei@163.com

Secretariat of the Organizing Committee:

● Email: ascnp2023@126.com

Conference Contact:Mr. Chen Min

● Phone: +86-13701842000

● Email: joe.chen@ccmtv.cn

Accommodation Booking:Ms. Lin Yu

● Tel: +86-18509201277

The Asian College of Neuropsychopharmacology (AsCNP) is a professional society established in Tokyo on October 1, 2007, primarily comprising psychiatric experts from the Asia-Pacific region. The society is committed to building a regional academic exchange platform for professionals engaged in psychopharmacology research and the clinical treatment of mental disorders in Asia. It aims to encourage and promote research in neuropsychopharmacology and mutual cooperation among Asian countries, improve pharmacotherapeutic techniques for mental disorders, and enhance recovery outcomes for patients with mental illnesses in Asia. The AsCNP Annual Meeting is a biennial international academic conference. The inaugural AsCNP International Congress was held in Kyoto, Japan, in 2009, attracting more than 1,000 scholars from the Asia-Pacific region. Subsequent congresses have been held in Seoul, South Korea (2011); Beijing, China (2013); Bali, Indonesia (2015); Taipei, China (2017); Fukuoka, Japan (2019); Singapore (2021); Xi’an, China (2023); and Australia (2025). Through these congresses, the society brings together global peers to jointly discuss industry hotspots and challenges, share cutting-edge technologies and future trends, and drive high-quality development in the field. It is currently one of the most authoritative benchmark societies in the psychiatric sector in Asia.

The China Schizophrenia Forum is a specialized forum within the academic field of Chinese psychiatry. Since its inception in 2013, the annually held “China Schizophrenia Forum” has become a landmark academic platform where psychiatrists in China convene to discuss basic and clinical research on schizophrenia, explore new treatment models, and share advances in academic research and clinical skills. It is attracting increasing attention and participation from psychiatrists.

The Annual Academic Conference on Psychiatry of the Shaanxi Medical Association is an academic conference aimed at improving the clinical diagnosis and treatment capabilities of psychiatric professionals and promoting the development of this specialty and related disciplines. The conference builds a bridge for external communication and provides a platform for internal exchange among psychiatrists and mental health professionals in Shaanxi Province. It encourages mental health workers across the province to continuously learn new theories and knowledge, thereby providing more professional services to patients with mental disorders.